 |
|
|
|
| ___________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________ |
| ___________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________ |
|
|
 |
|
|
In April 2005, the FDA issued an alert about the potential dangers of the painkiller Celebrex (celecoxib) in response to reports from several long-term National Institute of Health (NIH) prevention studies. The NIH studies indicated that the drug was associated with cardiovascular disorders and gastrointestinal bleeding that could lead to death. The FDA advised Pfizer, Inc., the drug maker, to include a boxed warning in the Celebrex (celecoxib) label indicating the potential for cardiovascular and gastrointestinal bleeding associated with its use.
The FDA identifies other risks of taking Celebrex to including liver damage, kidney problems and fluid retention, which can lead to heart failure.
The FDA had approved Celebrex in 1998 as a prescription relief for joint pain, stiffness, and swelling related to arthritis. It is also used for painful menstrual cycles and for acute pain in adults resulting from surgery or dental operations. Pfizer touts its “24 hour” effectiveness, but is now required to disclose its sometimes fatal side effects.
If you have taken Celebrex and think you have suffered any heart or gastrointestinal effects as a result, please obtain a Free Consultation by submitting our online form, or by calling 1-800-543-9859.
Here are some other perscription drugs that have recently been recalled or have been linked to illnesses in users:
|
|
 |
|
|
|
|
|
| __________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________ |
Don’t Hesitate to Contact Robert Peirce & Associates, P.C.
For a Free and Confidential Consultation
Robert Peirce & Associates, P.C.
2500 Gulf Tower, 707 Grant Street, Pittsburgh, PA 15219
P: 1-800-543-9859 F: 412-281-4229 |
| |
| Potential clients: Please be advised that submitting the "free consultation" form through our online system does not commit you to hiring our firm, and does not mean that you have retained an attorney for your potential case. The inquiry form will be reviewed by an attorney, and someone from Robert Peirce & Associates, P.C. will contact you to discuss the facts of your potential case. No attorney-client relationship is formed until a fee agreement is signed. We cannot guarantee the security of this site, and are not responsible for storing sensitive information. |
|
|
